Sandra Ortiz-Cuaran

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Small Cell Lung Cancer

Ejection Fraction

Patient Reported Outcomes

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Bautista Blaquier, Sandra Ortiz-Cuaran, Biagio Ricciuti, Laura Mezquita, Andrés Felipe Cardona, Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Juan Bautista Blaquier, Sandra Ortiz-Cuaran, Biagio Ricciuti, Laura Mezquita, Andrés Felipe Cardona, Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Juan Bautista Blaquier, Sandra Ortiz-Cuaran, Biagio Ricciuti, Laura Mezquita, Andrés Felipe Cardona, Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Nina Müller, Carina Lorenz, Jenny Ostendorp, Felix S Heisel, Ulrich P Friese, Maria Cartolano, Dennis Plenker, Hannah L Tumbrink, Alena Heimsoeth, Philipp Baedeker, Sandra Ortiz-Cuaran, Jonathan Weiss, Reinhard Buttner, Martin Peifer, Roman K Thomas, Martin L Sos, Johannes Berg, Johannes Brägelmann
Characterizing evolutionary dynamics reveals strategies to exhaust the spectrum of subclonal resistance in EGFR-mutant lung cancer. Cancer research (2023)